Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PNT

POINT Biopharma Global (PNT) Stock Price, News & Analysis

POINT Biopharma Global logo

About POINT Biopharma Global Stock (NASDAQ:PNT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$12.45
$14.23
52-Week Range
N/A
Volume
3.29 million shs
Average Volume
1.44 million shs
Market Capitalization
$1.33 billion
P/E Ratio
13.89
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for POINT Biopharma Global and its competitors with MarketBeat's FREE daily newsletter.

PNT Stock News Headlines

“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.tc pixel
Lilly Completes Acquisition of POINT Biopharma
See More Headlines

PNT Stock Analysis - Frequently Asked Questions

POINT Biopharma Global Inc. (NASDAQ:PNT) released its quarterly earnings results on Monday, November, 13th. The company reported ($0.23) earnings per share for the quarter, beating the consensus estimate of ($0.30) by $0.07. The business had revenue of $2.79 million for the quarter, compared to analysts' expectations of $8 million. POINT Biopharma Global had a net margin of 39.62% and a trailing twelve-month return on equity of 21.10%.

Based on aggregate information from My MarketBeat watchlists, some other companies that POINT Biopharma Global investors own include NVIDIA (NVDA), Broadcom (AVGO), Novo Nordisk A/S (NVO), Disc Medicine (IRON), Arista Networks (ANET), e.l.f. Beauty (ELF) and Builders FirstSource (BLDR).

Company Calendar

Last Earnings
11/13/2023
Today
8/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PNT
CIK
1811764
Fax
N/A
Employees
129
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.90
Trailing P/E Ratio
13.89
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$98.29 million
Net Margins
39.62%
Pretax Margin
52.16%
Return on Equity
21.10%
Return on Assets
18.28%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
9.14
Quick Ratio
9.14

Sales & Book Value

Annual Sales
$226.58 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
13.31
Book Value
$4.68 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
106,570,000
Free Float
89,518,000
Market Cap
$1.33 billion
Optionable
Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:PNT) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners